Liraglutide Cost in South Carolina: Prices, Insurance, and Savings Options (2026)

What Does Liraglutide Actually Cost in South Carolina?

The price you pay for liraglutide in South Carolina depends almost entirely on how you source it. Three pricing tiers exist. Novo Nordisk's list price for Saxenda (liraglutide 3.0 mg for weight management) sits at $1,349 per month. Retail pharmacies across South Carolina charge an average cash price of roughly $900 per month after negotiated discounts. Licensed 503A compounding pharmacies offer liraglutide for approximately $150 per month.

That six-fold gap between compounded and brand-name pricing explains why compounding has gained traction in the state. The SCALE Obesity and Prediabetes trial (N=3,731) demonstrated that liraglutide 3.0 mg produced 8.0% mean body weight loss versus 2.6% with placebo over 56 weeks, establishing the clinical basis for Saxenda's FDA approval. The drug works. The question for most South Carolinians is whether they can afford it.

Victoza (liraglutide 1.2 mg or 1.8 mg for type 2 diabetes) carries its own pricing structure, typically ranging from $800 to $1,000 per month without insurance. Both formulations use the same active molecule. The difference is the approved indication and target dose. Patients prescribed Victoza for diabetes may find broader insurance formulary coverage than those seeking Saxenda for weight loss, even in the same state and on the same plan.

South Carolina Medicaid Does Not Cover Liraglutide for Weight Management

South Carolina's Medicaid program does not include liraglutide (Saxenda) on its preferred drug list for chronic weight management. This mirrors the position of many state Medicaid programs. The Endocrine Society's 2015 Clinical Practice Guideline on pharmacological management of obesity recommends liraglutide 3.0 mg as a treatment option for adults with BMI ≥30 kg/m² or ≥27 kg/m² with a weight-related comorbidity, but Medicaid formulary decisions involve budget considerations beyond clinical evidence alone.

For type 2 diabetes, the picture may differ. SC Medicaid may cover Victoza (liraglutide 1.8 mg) under certain prior authorization conditions when prescribed specifically for glycemic control. Patients should verify current formulary status with the South Carolina Department of Health and Human Services, as preferred drug lists are updated quarterly.

Roughly 1.3 million South Carolinians receive Medicaid or CHIP benefits. For these residents, the lack of weight-management coverage effectively limits access to liraglutide to out-of-pocket payment or compounded alternatives. Dr. Robert Kushner, professor of medicine at Northwestern University Feinberg School of Medicine, has noted: "Coverage gaps for anti-obesity medications create a two-tiered system where patients who could benefit most from pharmacotherapy are least likely to access it."

Which SC Insurance Plans Cover Liraglutide?

Commercial insurance coverage for liraglutide in South Carolina varies by carrier, plan tier, and the prescribing indication. BlueCross BlueShield of South Carolina, the state's largest commercial insurer, typically requires prior authorization for Saxenda and may impose step therapy requirements (documented lifestyle modification for 3 to 6 months, or prior trial of another anti-obesity medication). When approved, copays range from $25 to $150 per month depending on the plan's specialty tier placement.

Other major SC carriers including Molina Healthcare, Absolute Total Care, and Select Health of South Carolina each maintain their own formulary rules. A pattern holds across most of them: diabetes indications receive broader coverage than weight-management indications for the same molecule. Plans offered through the federal Health Insurance Marketplace for South Carolina residents may cover Saxenda if the plan includes anti-obesity medication benefits, but this is not guaranteed under the ACA essential health benefits as currently defined.

The American Association of Clinical Endocrinology (AACE) 2024 consensus statement classifies obesity as a chronic disease warranting long-term pharmacotherapy, which has pressured some commercial plans to expand coverage. Still, South Carolina residents should call their insurer's pharmacy benefits line and request a formulary exception or prior authorization before filling a prescription.

Self-funded employer plans represent another avenue. Large employers in South Carolina, including the state government, BMW's Spartanburg operations, and Prisma Health, administer their own pharmacy benefits. Some have added GLP-1 receptor agonists for weight management to their formularies in 2025 and 2026 in response to employee demand and downstream healthcare cost projections. Employees should check with their HR or benefits department directly.

Compounded Liraglutide in South Carolina: Legal and Available

Compounded liraglutide is legal in South Carolina when dispensed by a licensed 503A compounding pharmacy with a valid patient-specific prescription. The FDA's guidance on compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound copies of commercially available drugs when certain conditions are met, including a valid prescription and an individual patient assessment.

At roughly $150 per month, compounded liraglutide costs approximately 89% less than brand-name Saxenda at list price. The savings are significant. So is the tradeoff. Compounded medications do not undergo FDA approval, and potency, sterility, and stability testing varies between compounding pharmacies. The FDA has issued warnings about risks associated with improperly compounded sterile injectables.

South Carolina residents considering compounded liraglutide should verify that the pharmacy holds a current South Carolina Board of Pharmacy license, maintains USP 797 and USP 800 compliance for sterile compounding, and provides certificates of analysis for each compounded batch. Accreditation by the Pharmacy Compounding Accreditation Board (PCAB) offers an additional layer of quality assurance, though it is not legally required in SC.

The South Carolina Board of Pharmacy regulates 503A compounding within the state. Patients can verify pharmacy licensure status through the board's online lookup tool. Out-of-state 503A pharmacies shipping into South Carolina must hold a nonresident pharmacy license issued by the SC board.

Novo Nordisk Savings Card and Other Discount Programs

Novo Nordisk offers the Saxenda Savings Card, which can reduce out-of-pocket costs for commercially insured patients to as little as $25 per month for up to 12 fills. The card cannot be used with government-funded insurance (Medicaid, Medicare, TRICARE, VA). Patients must have commercial insurance that covers Saxenda, even partially, to activate the savings card.

For uninsured patients, Novo Nordisk's Patient Assistance Program (PAP) provides Saxenda at no cost to qualifying individuals with household income at or below 400% of the federal poverty level. In 2026, that threshold equals $62,400 for a single-person household. The application requires income documentation and a prescriber signature.

Other discount pathways available to SC residents include GoodRx, RxSaver, and similar pharmacy discount aggregators. These platforms negotiate cash-pay rates below the retail average. In South Carolina markets, GoodRx coupons have shown liraglutide prices between $750 and $950 per month depending on the pharmacy, still well above compounded pricing but below the $1,349 list price.

The SCALE Maintenance trial showed that patients who discontinued liraglutide regained approximately two-thirds of lost weight within 12 months. This finding underscores that liraglutide therapy is typically long-term, making monthly cost a sustained financial consideration rather than a one-time expense.

Telehealth Prescribing of Liraglutide Is Legal in South Carolina

South Carolina permits telehealth prescribing of liraglutide. The state's Telemedicine Act allows licensed prescribers to evaluate patients via audio-video communication and prescribe medications, including controlled and non-controlled substances, when clinically appropriate. Liraglutide is not a controlled substance, which simplifies the prescribing pathway.

Multiple telehealth platforms now serve South Carolina residents for GLP-1 receptor agonist prescriptions. These platforms typically charge a monthly membership fee ($50 to $199) on top of the medication cost. Some bundle compounded liraglutide with the telehealth consultation at a combined price of $200 to $350 per month.

Telehealth has expanded access particularly for patients in rural SC counties. Of South Carolina's 46 counties, the Health Resources and Services Administration (HRSA) designates portions of 39 as primary care Health Professional Shortage Areas. For residents in these areas, driving 60 or more miles to an obesity medicine specialist is common. Telehealth removes that barrier.

The prescribing physician must hold an active South Carolina medical license or a license through the Interstate Medical Licensure Compact, which South Carolina joined. Prescriptions can be sent electronically to any licensed pharmacy in the state, including compounding pharmacies.

How Liraglutide Compares to Other GLP-1 Options on Price in SC

Liraglutide is not the only GLP-1 receptor agonist prescribed for weight management or diabetes in South Carolina. Semaglutide (Wegovy for weight loss, Ozempic for diabetes) is the most common alternative. Tirzepatide (Zepbound for weight loss, Mounjaro for diabetes) represents a dual GIP/GLP-1 receptor agonist option.

On price, semaglutide 2.4 mg (Wegovy) carries a list price of approximately $1,349 per month, identical to Saxenda. Tirzepatide (Zepbound) lists at approximately $1,059 per month. Compounded semaglutide, when available through 503A pharmacies, ranges from $150 to $300 per month in SC markets. Compounded tirzepatide pricing is similar.

Liraglutide's clinical profile differs from these alternatives. The SCALE trial demonstrated 8.0% mean weight loss with liraglutide 3.0 mg over 56 weeks. By comparison, the STEP-1 trial (N=1,961) showed semaglutide 2.4 mg producing 14.9% mean weight loss at 68 weeks versus 2.4% with placebo, and the SURMOUNT-1 trial (N=2,539) showed tirzepatide 15 mg producing 20.9% weight loss at 72 weeks.

Liraglutide requires daily injections. Semaglutide and tirzepatide are weekly. For some patients, the daily dosing of liraglutide allows finer dose titration and may produce fewer GI side effects during the escalation period. The FDA's prescribing information for Saxenda recommends a 5-week titration schedule starting at 0.6 mg and increasing by 0.6 mg weekly to the target 3.0 mg dose.

Practical Steps to Get Liraglutide in South Carolina at the Lowest Cost

A clear decision path exists. Start by checking your insurance formulary. Call the number on the back of your pharmacy benefit card and ask whether Saxenda or Victoza requires prior authorization and what your expected copay would be. If covered with a reasonable copay, request the Novo Nordisk Savings Card to reduce costs further.

If your plan does not cover liraglutide or the copay exceeds your budget, evaluate compounded liraglutide. Confirm the compounding pharmacy is licensed by the South Carolina Board of Pharmacy and follows USP 797 sterile compounding standards. Ask for a certificate of analysis. Expect pricing near $150 per month.

If you are uninsured and your income falls below 400% of the federal poverty level, apply for Novo Nordisk's Patient Assistance Program before paying out of pocket. The program can take 2 to 4 weeks for approval.

The Endocrine Society recommends that pharmacotherapy for obesity be combined with lifestyle intervention, including reduced-calorie diet and 150 minutes per week of moderate-intensity physical activity, to maximize treatment response. Dr. Caroline Apovian, co-director of the Center for Weight Management and Wellness at Brigham and Women's Hospital, has stated: "Medication alone produces meaningful weight loss, but the combination of pharmacotherapy with behavioral change consistently produces the largest and most durable effects in clinical trials."

Residents of South Carolina who fill liraglutide prescriptions through telehealth should confirm that their chosen platform's prescriber holds an active SC license and that the prescription will be sent to a pharmacy they can access, whether a local retail chain or a mail-order compounding pharmacy licensed in the state.